alexa Yusuf Tutar | Cumhuriyet University
ISSN: 2169-0138

Drug Designing: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Yusuf Tutar

Yusuf Tutar Yusuf Tutar
Department of Basic Sciences
Biochemistry Division
Cumhuriyet University

Read Interview session with Yusuf Tutar

Dr. Yusuf TUTAR is the Head of Biochemistry Division and the head of Basic Sciences Department at Faculty of Pharmacy, Cumhuriyet University, Sivas Turkey. Dr. Tutar is also the Head of Biomedical Engineering Program at the same university. He obtained his M.Sc. and Ph.D. at Oregon State University and Texas Tech University respectively. He pursued his postdoctoral study at National Institutes of Health (NIH/NIDDK), USA. His research focuses on Biochemistry, Biophysics, Genetics and Molecular Biology with specialization in the fields of protein structure-function, protein folding, prion, microrna, pseudogenes, molecular cancer, proteomics, genomics, protein expression and characterization by spectroscopic and calorimetric methods.

Research Interest

Investigating structure-function relationship of biological macromolecules with biochemical, biophysical, genetics and molecular biological methods. Recombinant DNA technology, molecular sub-cloning, transformation and protein expression.
Protein purification (Heat shock, Catabolite repressor ve S100P proteins) and characterisation (Spectroscopy: Fluorescence, Luminescence, CD, FTIR; Calorimetry: NanoDSC and ITC; Chromatography: HPLC and FPLC; Other techniques: MALDI-TOF, GC).
Molecular Cancer Research (Prostate, thyroid, renal, colon) and epigenetic (RT-PCR and Microarray). • MicroRNA, pseudogens and transfection.
Prion, translation termination in eukaryotes, and transcription initiation in prokaryotes.


Global Speakers in the subject

Global Experts in the subject


New Generation Cancer Drug Studies: Hsp90 Inhibitors
Lutfi Tutar, Kubra Acikalin Coskun and Yusuf Tutar
Editorial: Single Cell Biol 2016, 5: e124
DOI: 10.4172/2168-9431.1000e124
Editor Note
Yusuf Tutar
Editor Note: Drug Des 2016, 5: 2
DOI: 10.4172/2169-0138.1000e132
Editor Note: Single Cell Biology
Yusuf Tutar
Editor Note: Single Cell Biol 2015, 5: e123
DOI: 10.4172/2168-9431.1000e123
Current Drug Design Studies for Hsp70 in Oncological Applications
Kubra Acikalin Coskun, Lutfi Tutar and Yusuf Tutar
Editorial: Cell Dev Biol 2016, 5:e140
DOI: 10.4172/2168-9296.1000e140
Structure Based Drug Design for Heat Shock Proteins
Lutfi Tutar, Kubra Acikalin Coskun and Yusuf Tutar
Editorial: Drug Des 2016, 5: 2
DOI: 10.4172/2169-0138.1000e130
Heat Shock Protein as Emerging Oncologic Drug Targets
Lutfi Tutar, Kübra Açıkalın Coskun and Yusuf Tutar
Short Communication: J Dev Drugs
DOI: 10.4172/2329-6631.1000155
Heat Shock Proteins: An Important Targets for Development of Next Generation Cancer Drugs
Aykut Özgür and Yusuf Tutar
Short Communication: Journal of Pharmacy and Pharmaceutical Sciences
Aurora Kinase Inhibitors in Target Specific Cancer Treatment
Yusuf Tutar
Commentary: Journal of Pharmacy and Pharmaceutical Sciences
Diazepine Derivative Compounds as Heat Shock Protein 90 Inhibitor in Oncology
Yusuf Tutar
Editorial: Drug Des 2015, 4: e127
DOI: 10.4172/2169-0138.1000e127
Heat Shock Proteins, microRNAs, and Drug Design Studies in Medicinal Chemistry
Yusuf Tutar
Short Communication: Single Cell Biol 2015, 4: 112
DOI: 10.4172/2168-9431.1000112
Biomimetic Marine Material Chitosan and its Applications
Yusuf Tutar
Short Communication: Single Cell Biol 2015, 4: 110
DOI: 10.4172/2168-9431.1000110
Inhibition of Heat Shock Protein 70 and 90 (Hsp70 And Hsp90) in Target Spesific Cancer Treatment
Yusuf Tutar
Editorial: Adv Tech Biol Med 2015, e109
DOI: 10.4172/2379-1764.1000e109

Drug Designing: Open Access - Heat shock protein, oncogenic pathways, Proliferation assay, Estrogen receptor

Drug Design Studies

Presented by: Yusuf Tutar
Biochemistry Division, Cumhuriyet University

Download PPT PPT Views: 229 Updated on: 2015-10-13 For Recent Update: Click here
Download PDF   PDF Views: 229  Updated on: 2015-10-13 For Recent Update: Click here
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

1-702-714-7001Extn: 9037

Business & Management Journals


1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version